Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals.
暂无分享,去创建一个
G. Huez | M. Loos | C. Biernaux | A. Sels | P. Stryckmans | M. Loos
[1] D. Jong,et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. , 1995, Blood.
[2] D. Shibata,et al. BCL2 translocation frequency rises with age in humans. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] T. Lion,et al. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT). , 1993, Leukemia.
[4] S. Sowerby,et al. DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias. , 1993, Oncogene.
[5] J. Tanzer,et al. Quantitative determination of the hybrid Bcr‐Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy , 1992, British journal of haematology.
[6] H. Kantarjian,et al. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation , 1992, British journal of haematology.
[7] G. Rosti,et al. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants. , 1992, Leukemia.
[8] J. D. Thompson,et al. Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation. , 1992, Blood.
[9] P. Ely,et al. bcr/abl mRNA DETECTION FOLLOWING BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA , 1991, Transplantation.
[10] E. Thiel,et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction , 1991, The Lancet.
[11] M. Slovak,et al. Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase. , 1991, Transplantation.
[12] C. Marcelle,et al. Analysis of BCR‐ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR‐related sequence in human DNA , 1989, Genes, chromosomes & cancer.
[13] R. Marcus,et al. Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis , 1989, British journal of haematology.
[14] S. Smith,et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[15] N. Heisterkamp,et al. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia , 1987, Cell.
[16] G. Daley,et al. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Deeg,et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. , 1986, Annals of internal medicine.
[18] R. Marcus,et al. Bone marrow transplantation for patients with chronic myeloid leukemia. , 1986, The New England journal of medicine.
[19] J. Stephenson,et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.
[20] C. Bloomfield,et al. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. , 1983, Cancer research.
[21] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[22] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.
[23] J. Melo,et al. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. , 1994, Leukemia.
[24] H. Saito,et al. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. , 1993, Blood.
[25] T. Lion,et al. Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. , 1992, Leukemia.
[26] R. Kurzrock,et al. Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction. , 1992, Leukemia.
[27] D. Ginsburg,et al. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. , 1992, Blood.
[28] R. Kurzrock,et al. Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia. , 1987, Blood.
[29] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[30] P. Nowell,et al. A minute chromosome in human chronic granulocytic leukemia , 1960 .